Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis [0.03%]
奥贝胆酸治疗非酒精性脂肪肝病前肝硬化性肝纤维化的REGENERATE试验的新疗效和安全性分析结果
Arun J Sanyal,Vlad Ratziu,Rohit Loomba et al.
Arun J Sanyal et al.
Background & aims: Obeticholic acid (OCA) is a first-in-class farnesoid X receptor agonist and antifibrotic agent in development for the treatment of pre-cirrhotic liver fibrosis due to non-alcoholic steatohepatitis (NASH...
Reply to: "Non-invasive testing for advanced fibrosis in patients with diabetes with fatty liver disease needs further evaluation of cut-off values" [0.03%]
关于"糖尿病肝脂肪变患者检测肝纤维化的无创指标需要进一步验证其切点值"的回答
Veeral Ajmera,Rohit Loomba
Veeral Ajmera
Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes [0.03%]
代谢生物标志物可显著增强HBV相关急性肝功能衰竭发生和预后的预测能力
Yan Zhang,Wenting Tan,Xianbo Wang et al.
Yan Zhang et al.
Background & aims: Acute-on-chronic liver failure (ACLF) is a clinical syndrome associated with high short-term mortality in patients with chronic liver disease. Chronic hepatitis B is the main cause of ACLF (HBV-ACLF) in...
Reply to: Correspondence on "Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod" [0.03%]
关于“肝肺综合征与低鞘氨醇-1-磷酸水平有关，并可通过功能激动剂芬戈莫德改善”的来信的回信
Sukriti Baweja,Chhagan Bihari,Anupama Kumari et al.
Sukriti Baweja et al.
Excellent long-term outcomes after sequential hypothermic and normothermic machine perfusion challenges the importance of functional donor warm ischemia time in DCD liver transplantation [0.03%]
程序化低温机器灌注和常温机器灌注优化捐赠后肝脏的移植效果：DCD肝移植中供肝温暖缺血时间功能作用再思考
Otto B van Leeuwen,Silke B Bodewes,Robert J Porte et al.
Otto B van Leeuwen et al.
Pellet-based hepatitis C virus treatment with glecaprevir/pibrentasvir: A case report of an adult with short bowel syndrome [0.03%]
基于颗粒的丙型肝炎病毒治疗（ glecaprevir/pibrentasvir）：一例短肠综合征成年患者的病例报告
Michelle T Martin,Sonalie Patel,Wadih Chacra
Michelle T Martin
Improving outcomes of in situ split liver transplantation in Italy over the last 25 years [0.03%]
意大利原位劈离肝移植25年经验总结及改进措施
Andrea Lauterio,Umberto Cillo,Marco Spada et al.
Andrea Lauterio et al.
Background & aims: Split liver transplant(ation) (SLT) is still considered a challenging procedure that is by no means widely accepted. We aimed to present data on 25-year trends in SLT in Italy, and to investigate if, an...
Reply to: Comments on "Risk of parenterally transmitted hepatitis following exposure to invasive procedures in Italy: SEIEVA surveillance 2000-2021" [0.03%]
关于“意大利侵入性操作后家长传播性肝炎风险：SEIEVA 监测（2000-2021）”的评论回复
Maria Elena Tosti,Susanna Caminada,Luigina Ferrigno
Maria Elena Tosti
Ammonia predicts clinical outcomes in cirrhosis - but there are caveats to consider [0.03%]
ammonia预测肝硬化的临床结局但仍需考虑一些限制因素
Elliot B Tapper,Jasmohan S Bajaj
Elliot B Tapper